ERLAD-hERG axis and L-type calcium channel activation mediate cholesterol-induced acquired long QT syndrome-related cardiotoxicity.
- DOI
- 10.1016/j.ejphar.2026.179216
- Published
- 2026 Sep 10
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179216,
title = {ERLAD-hERG axis and L-type calcium channel activation mediate cholesterol-induced acquired long QT syndrome-related cardiotoxicity.},
author = {Ma L and Teng W and Liu XY and Song Y and Yi ZS and Li XX and Li YX and Ding QR and Zhou YY and Sun X and Hong HY and Li BX},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179216},
url = {https://doi.org/10.1016/j.ejphar.2026.179216}
}RIS
TY - JOUR TI - ERLAD-hERG axis and L-type calcium channel activation mediate cholesterol-induced acquired long QT syndrome-related cardiotoxicity. AU - Ma L AU - Teng W AU - Liu XY AU - Song Y AU - Yi ZS AU - Li XX AU - Li YX AU - Ding QR AU - Zhou YY AU - Sun X AU - Hong HY AU - Li BX PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179216 UR - https://doi.org/10.1016/j.ejphar.2026.179216 ER -
APA
L, M., W, T., XY, L., Y, S., ZS, Y., XX, L., YX, L., QR, D., YY, Z., X, S., HY, H., & BX, L. (2026). ERLAD-hERG axis and L-type calcium channel activation mediate cholesterol-induced acquired long QT syndrome-related cardiotoxicity.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179216
Source records
- pubmed · retrieved 2026-09-25T19:24:47.057Z